Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

cse:lxx

POPULAR ARTICLES

Lexaria Bioscience secures U.S. patent for drug delivery technology

Lexaria Bioscience secures U.S. patent for drug delivery technology

Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4

Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4

Lexaria Enters One-Year Media Outreach Agreement with SRAX, Inc.

Lexaria Enters One-Year Media Outreach Agreement with SRAX, Inc.

LATEST ARTICLES

Lexaria's Clinical Hypertension Study HYPER-H21-3 Nears Completion

Lexaria's Clinical Hypertension Study HYPER-H21-3 Nears Completion

Lexaria's DehydraTECHTM-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2

Lexaria's DehydraTECHTM-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2

Lexaria's DehydraTECH-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2

Lexaria's DehydraTECH-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2

Lexaria Bioscience Corp. Announces Participation in the Benzinga Global Small Cap Conference

Lexaria Bioscience Corp. Announces Participation in the Benzinga Global Small Cap Conference

aria alzheimer

Lexaria 2022 R&D Programs to Include Investigations into Alzheimer's Disease and Diabetes

bio ionic 10x

Lexaria Announces Ambitious New Hypertension Study HYPER-H21-4

active bioscience

Lexaria Announces R&D Program to Compare First and Only FDA-Approved Prescription Cannabidiol

artificial graphite block

Lexaria THC Test Results Come in as MORE Act Gains Momentum in Congress

biotech investing podcast

IBN Announces Latest Episode of Stock2Me Podcast Featuring Lexaria Bioscience Corp. Chairman & CEO Chris Bunka

nicatine pouches

DehydraTECH Nicotine Pouches Could Make Smoking Obsolete

wellteq

BTV Highlights Promising Investment Opportunities

avtbf stock

Lexston Life Sciences Corp. Acquires Zenalytic Laboratories Ltd.

Latest News

Westport Announces Annual General and Special Meeting and Timing of Q1 2025 Financial Results

Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties

Canadian Investment Regulatory Organization Trade Resumption - FYL

Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties

Forte Minerals Engages Trion Communications GmbH for European Investor Awareness